367 related articles for article (PubMed ID: 18758202)
1. Controlled-release oxycodone in the treatment of neuropathic pain of nonmalignant and malignant causes.
Ong EC
Oncology; 2008; 74 Suppl 1():72-5. PubMed ID: 18758202
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.
Nicholson B; Ross E; Sasaki J; Weil A
Curr Med Res Opin; 2006 Aug; 22(8):1503-14. PubMed ID: 16870075
[TBL] [Abstract][Full Text] [Related]
3. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study.
Portenoy RK; Farrar JT; Backonja MM; Cleeland CS; Yang K; Friedman M; Colucci SV; Richards P
Clin J Pain; 2007 May; 23(4):287-99. PubMed ID: 17449988
[TBL] [Abstract][Full Text] [Related]
4. Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain - results from a large observational study.
Hermanns K; Junker U; Nolte T
Expert Opin Pharmacother; 2012 Feb; 13(3):299-311. PubMed ID: 22224497
[TBL] [Abstract][Full Text] [Related]
5. Use of oxycodone controlled-release immediately after NSAIDs: a new approach to obtain good pain control.
Tessaro L; Bandieri E; Costa G; Fornasier G; Iorno V; Pizza C; Pastacaldi G; Micheletto G
Eur Rev Med Pharmacol Sci; 2010 Feb; 14(2):113-21. PubMed ID: 20329570
[TBL] [Abstract][Full Text] [Related]
6. Patient-controlled analgesia versus oral controlled-release oxycodone - are they interchangeable for acute postoperative pain after laparoscopic colorectal surgeries?
Ho HS
Oncology; 2008; 74 Suppl 1():61-5. PubMed ID: 18758200
[TBL] [Abstract][Full Text] [Related]
7. [Controlled-release oxycodone--a therapeutic option for severe neuropathic pain. Two multicenter observational studies].
Wörz R; Frank M; Achenbach U
MMW Fortschr Med; 2003 Oct; 145 Suppl 3():71-6. PubMed ID: 15490770
[TBL] [Abstract][Full Text] [Related]
8. Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe postherpetic neuralgia pain.
Fan BF;
Oncology; 2008; 74 Suppl 1():66-71. PubMed ID: 18758201
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: a prospective, age-group-controlled study.
Likar R; Wittels M; Molnar M; Kager I; Ziervogel G; Sittl R
Clin Ther; 2006 Dec; 28(12):2022-39. PubMed ID: 17296459
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological approach to chronic visceral pain. Focus on oxycodone controlled release: an open multicentric study.
Liguori S; Gottardi M; Micheletto G; Bruno L
Eur Rev Med Pharmacol Sci; 2010 Mar; 14(3):185-90. PubMed ID: 20391956
[TBL] [Abstract][Full Text] [Related]
11. Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain.
Hagen NA; Babul N
Cancer; 1997 Apr; 79(7):1428-37. PubMed ID: 9083166
[TBL] [Abstract][Full Text] [Related]
12. Oxycodone improves pain control and quality of life in anticonvulsant-pretreated spinal cord-injured patients with neuropathic pain.
Barrera-Chacon JM; Mendez-Suarez JL; Jáuregui-Abrisqueta ML; Palazon R; Barbara-Bataller E; García-Obrero I
Spinal Cord; 2011 Jan; 49(1):36-42. PubMed ID: 20820176
[TBL] [Abstract][Full Text] [Related]
13. Oxycodone and the challenge of neuropathic cancer pain: a review.
Núñez Olarte JM
Oncology; 2008; 74 Suppl 1():83-90. PubMed ID: 18758204
[TBL] [Abstract][Full Text] [Related]
14. Prolonged-release oxycodone/naloxone in nonmalignant pain: single-center study in patients with constipation.
Gatti A; Casali M; Lazzari M; Tufaro G; Gafforio P; Silvestri C; Marcassa C; Sabato AF
Adv Ther; 2013 Jan; 30(1):41-59. PubMed ID: 23269562
[TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.
Meissner W; Leyendecker P; Mueller-Lissner S; Nadstawek J; Hopp M; Ruckes C; Wirz S; Fleischer W; Reimer K
Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438
[TBL] [Abstract][Full Text] [Related]
16. Codeine and oxycodone use in patients with chronic rheumatic disease pain.
Ytterberg SR; Mahowald ML; Woods SR
Arthritis Rheum; 1998 Sep; 41(9):1603-12. PubMed ID: 9751092
[TBL] [Abstract][Full Text] [Related]
17. [Controlled-release oxycodone -- a therapeutic option for severe neuropathic pain].
Wörz R; Frank M; Achenbach U
MMW Fortschr Med; 2003 Sep; 145(39):45. PubMed ID: 14649073
[No Abstract] [Full Text] [Related]
18. [Controlled release oxycodone--a new option in the treatment of severe and very severe pain. Review of studies on neuropathic, physical activity-related and postoperative pain].
Stiehl M
MMW Fortschr Med; 2004 Aug; 146 Suppl 2():61-9. PubMed ID: 16739361
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
[TBL] [Abstract][Full Text] [Related]
20. Analgesic efficacy of controlled-release oxycodone in patients with uterine or ovarian cancer.
Suzuki T; Morishita M; Ito E; Matsuura M; Tanaka R; Saito T
Am J Ther; 2008; 15(1):31-5. PubMed ID: 18223351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
